Jump Financial’s Atea Pharmaceuticals AVIR Stock Holding History

Jump Financial’s Portfolio AVIR Stock Details AVIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$476K	Buy	102,421 +9,174	+10%	+$45.6K	﹤0.01%	1473
2026 Q1	$502K	Buy	93,247 +74,134	+388%	+$340K	0.01%	1241
2025 Q4	$68.2K	Buy	19,113 +3,106	+19%	+$9.87K	﹤0.01%	1855
2025 Q3	$46.4K	Buy	+16,007	New	+$54.7K	﹤0.01%	1721
2023 Q1	–	Sell	-60,400	Closed	-$291K	–	1573
2022 Q4	$291K	Buy	+60,400	New	+$306K	0.02%	1066
2021 Q4	–	Sell	-43,100	Closed	-$1.51M	–	1376
2021 Q3	$1.51M	Buy	43,100 +31,100	+259%	+$863K	0.11%	208
2021 Q2	$258K	Buy	12,000 +8,369	+230%	+$251K	0.02%	736
2021 Q1	$224K	Buy	+3,631	New	+$245K	0.02%	724

Other funds holding AVIR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jump Financial's AVIR Position: Q2 2026 in Review

Jump Financial increased its Atea Pharmaceuticals (AVIR) stake by 9.8% in Q2 2026, buying an estimated $45.6K and bringing the position to 102,421 shares worth $476K. The position accounts for ﹤0.01% of the portfolio, ranked #1473.

Jump Financial first reported a position in AVIR in Q1 2021 and has held it in 8 quarters since. The position peaked at $1.51M in Q3 2021. 124 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

Jump Financial held 102,421 shares of Atea Pharmaceuticals worth $476K as of Q2 2026.
Jump Financial bought 9,174 Atea Pharmaceuticals shares in Q2 2026, an estimated $45.6K.
Atea Pharmaceuticals made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1473 holding.
Jump Financial first reported a position in Atea Pharmaceuticals in Q1 2021 and has held it in 8 quarters since.
Jump Financial's Atea Pharmaceuticals position peaked at $1.51M in Q3 2021.
124 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.